The Advisory Board of the Bioengineering Program provides input on academics, research, administration, outreach, advocacy, and development. The Board reviews the undergraduate curriculum and degree programs, program educational objectives, and program outcomes, and offers suggestions for change to keep them current. The Board evaluates the quality and scope of our research, its relationship to our programs, its relevancy and helps guide future directions. The Board recommends ways to build new relationships with industry and to strengthen those we have. The current members of the Advisory Board are:
Ph.D., Principal, Program Management, Product Realization Group
Ph.D., George A. and Hilda M. Daubert Professor, Department of Chemistry, Stanford University
Vice President, Research & Development, Invuity
F.K., M.A., Ph.D., CCC-SLP, FASHA
Executive Director Howard and Alida Charney, University Professor of Science and Technology for Social Benefit
Managing Director, GVMED
Ph.D., Fellow of AIMBE
Director, Coronis Medical Ventures
Ph.D., Douglass M. & Nola Leishman Prof. of Cardiovascular Disease, Department of Biochemistry & Dept. of Developmental Biology, Stanford University School of Medicine
Chairman/CTO/Co-Founder, Siesta Medical, Inc.
Ph.D., Co-Founder & Senior Vice President, Second Genome Inc.